Scholarlink

<p>Financial toxicity is a neglected complication following the long-drawn treatment of ovarian cancer. In a low- and middle-income country like India, where private hospitals usually deliver cancer care, financial hardship is a real-time challenge to patients, their families, and the generations to come. This review aims to acknowledge the issue, discuss the reasons and the impact of financial toxicity, and suggest strategies to mitigate the financial burden of patients with ovarian cancer. Financial toxicity in ovarian cancer can be secondary to direct costs of treatment such as diagnostic workup, surgery, and chemotherapy and indirect costs due to money spent on commute, lodging, and loss of wages. The impact of financial toxicity can be profound, and patients often resort to economic and behavioral coping strategies that can affect the patient's family for a lifetime and beyond. In a country like India, where the patient often relies on public insurance or no insurance, it is prudent to acknowledge financial toxicity, screen patients early for financial toxicity, utilize evidence-based cost-effective guidelines, and avoid low-volume measures.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Financial Toxicity and Optimal Care in Ovarian Cancer—Perspective from Low Middle Income Countries

  • 期刊论文

  • 发表日期：

    2025年1月17日

查看全文
  • Vinotha Thomas,
  • Anjana Joel,
  • Jenifer Jeba Sundararaj,
  • Anuradha Chandramohan,
  • Abraham Peedicayil

摘要

Financial toxicity is a neglected complication following the long-drawn treatment of ovarian cancer. In a low- and middle-income country like India, where private hospitals usually deliver cancer care, financial hardship is a real-time challenge to patients, their families, and the generations to come. This review aims to acknowledge the issue, discuss the reasons and the impact of financial toxicity, and suggest strategies to mitigate the financial burden of patients with ovarian cancer. Financial toxicity in ovarian cancer can be secondary to direct costs of treatment such as diagnostic workup, surgery, and chemotherapy and indirect costs due to money spent on commute, lodging, and loss of wages. The impact of financial toxicity can be profound, and patients often resort to economic and behavioral coping strategies that can affect the patient's family for a lifetime and beyond. In a country like India, where the patient often relies on public insurance or no insurance, it is prudent to acknowledge financial toxicity, screen patients early for financial toxicity, utilize evidence-based cost-effective guidelines, and avoid low-volume measures.